0001192482-21-000241.txt : 20210310
0001192482-21-000241.hdr.sgml : 20210310
20210310202433
ACCESSION NUMBER: 0001192482-21-000241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210310
DATE AS OF CHANGE: 20210310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casten Richard S
CENTRAL INDEX KEY: 0001850307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39101
FILM NUMBER: 21731482
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Baudax Bio, Inc.
CENTRAL INDEX KEY: 0001780097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 474639500
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-395-2470
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Recro Enterprises, Inc.
DATE OF NAME CHANGE: 20190618
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-03-08
0001780097
Baudax Bio, Inc.
BXRX
0001850307
Casten Richard S
C/O BAUDAX BIO, INC.
490 LAPP ROAD
MALVERN
PA
19355
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-08
4
A
0
15000
0
A
15000
D
Common Stock
2021-03-08
4
A
0
85000
0
A
100000
D
Stock Option (right to buy)
1.21
2021-03-08
4
A
0
15000
0
A
2031-03-08
Common Stock
15000
15000
D
Stock Option (right to buy)
1.21
2021-03-08
4
A
0
255000
0
A
2031-03-08
Common Stock
255000
255000
D
These restricted stock units will vest in full on December 31, 2021, subject to continued service with the Company.
These restricted stock units will vest in four equal annual installments beginning on March 8, 2022, subject to continued service with the Company.
The stock option will vest in full on December 31, 2021, subject to continued service with the Company.
The stock option vests in equal monthly installments over 48 months, beginning on April 8, 2021, subject to continued service to the Company.
/s/ Richard S. Casten
2021-03-10